Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTERN steroid reduction trial in relapsing nephrotic syndrome
NL-OMON47536Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of prednisolone and Placebo-COD Research Private Ltd in nephrosis (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Time till first relapse. Started Dec 2016; status: recruiting.
02
Drugs
prednisolonePlacebo-COD Research Private Ltd
03
Conditions
nephrosis
Beyond the preview
Go deeper on NL-OMON47536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47536.